Onco-Innovations Limited
ONCO
| 04/30/2026 | 01/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -54.14% | -26.13% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -50.57% | -26.72% | |||
| Operating Income | 51.47% | 25.11% | |||
| Income Before Tax | 51.74% | 14.00% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 51.74% | 14.00% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 51.74% | 14.00% | |||
| EBIT | 51.47% | 25.11% | |||
| EBITDA | -- | -- | |||
| EPS Basic | 53.54% | 17.33% | |||
| Normalized Basic EPS | 53.63% | 17.06% | |||
| EPS Diluted | 53.54% | 17.33% | |||
| Normalized Diluted EPS | 53.63% | 17.06% | |||
| Average Basic Shares Outstanding | 3.64% | 3.98% | |||
| Average Diluted Shares Outstanding | 3.64% | 3.98% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||